Spyre Therapeutics
SYRE
SYRE
23 hedge funds and large institutions have $38.5M invested in Spyre Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.13% less ownership
Funds ownership: 1.67% → 1.54% (-0.13%)
12% less funds holding
Funds holding: 26 → 23 (-3)
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$814K | |
| 2 | +$617K | |
| 3 | +$294K | |
| 4 |
Renaissance Technologies
New York
|
+$270K |
| 5 |
Bank of New York Mellon
New York
|
+$157K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$1.52M | |
| 3 | -$722K | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$275K |
| 5 |
SCM
Sio Capital Management
New York
|
-$138K |